Theon Pharma Launches India's First Vonoprazan Triple Therapy Kit

Theon Pharmaceuticals launched India's first triple therapy kit combining vonoprazan, amoxicillin, and clarithromycin to treat Helicobacter pylori infections.

The kit uses vonoprazan, a potassium-competitive acid blocker, to provide stronger acid suppression than traditional proton pump inhibitors for better antibiotic effectiveness.

The co-packaged format aims to simplify the treatment regimen for patients suffering from peptic ulcers and gastric cancer risks by reducing medication complexity.